ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2022 American Transplant Congress

    Deletion of AIF-1 Promotes Kidney Reparative Macrophages and Prevents Fibrosis

    I. Husain, A. Dangi, X. Luo

    Duke University School of Medicine, Durham, NC

    *Purpose: A major etiology contributing to poor allograft survival is the inevitable ischemic insult it incurs during transplantation. Macrophages are key players in ischemia-reperfusion injury,…
  • 2022 American Transplant Congress

    Urine-based Assay For Detection Of Acute Rejection In Pediatric Kidney Transplant Recipients

    C. Crane1, K. Zeeb2, E. Phebus2, C. Benavides2, W. Wong3, E. Ingulli2

    1UCSD/Rady Children's Hospital, San Diego, CA, 2UCSD Rady Children's Hospital, San Diego, CA, 3Massachusetts General Brigham, Boston, MA

    *Purpose: Biomarkers such as donor-derived cell free DNA (cfDNA) and gene expression profiling are utilized in adult transplant patients (pts), but these tests lack sensitivity…
  • 2022 American Transplant Congress

    Benefit of Kidney Transplantation for Post Lung Transplantation Renal Failure: Need for Priority Allocation

    S. Karhadkar1, A. Gregor1, K. Jonathan1, J. Dawes1, A. Diamond2, K. Wirshup1, A. DiCarlo1

    1Temple University Hospital, Philadelphia, PA, 2-, Garnet Valley, PA

    *Purpose: Nephrotoxicity is a major side effect of thoracic transplantation. Many patients will eventually require renal transplantation (KAL) to manage their developing ESRD. Recently, simultaneous…
  • 2022 American Transplant Congress

    Low-Quality Kidney Allograft Use in Kidney Transplantation is Associated with a Prolonged Post-Transplant Length of Stay

    J. A. Kahla1, C. R. Goff1, J. A. Goss2, A. A. Rana2

    1Department of Student Affairs, Baylor College of Medicine, Houston, TX, 2Division of Abdominal Transplantation, Michael E DeBakey Department of General Surgery, Baylor College of Medicine, Houston, TX

    *Purpose: The purpose of this study is to determine the effect of low-quality kidney allografts on recipient hospital length of stay following transplant using five…
  • 2022 American Transplant Congress

    Safety and Efficacy of SGLT-2 Inhibitors in Solid Organ Transplant Recipients

    E. Heiman, D. Blanco, A. Webb

    Pharmacy, Tampa General Hospital, Tampa, FL

    *Purpose: Sodium-glucose co-transporter 2 inhibitors (SGLT2i) have been shown to improve glycemic control, blood pressure, cardiovascular mortality, and preserve kidney function in the general population.…
  • 2022 American Transplant Congress

    Dynapenia Among Kidney Transplant Candidates and Recipients in the United States

    A. S. Nalatwad1, X. Chen1, N. M. Chu1, S. P. Norman2, D. L. Segev1, M. McAdams-Demarco1

    1Epidemiology Research Group in Organ Transplantation, Johns Hopkins University School of Medicine, Baltimore, MD, 2Univ of Michigan Medical Ctr, Ann Arbor, MI

    *Purpose: Among Kidney Transplant (KT) patients, sarcopenia, loss of muscle mass, is prevalent and has been associated with post-KT mortality. The burden of dynapenia, an…
  • 2022 American Transplant Congress

    Outcomes of Kidney Transplantation from a Male Donor with a Highly Elevated Prostate Specific Antigen Level (PSA) in Female Recipients

    S. K. Patel, E. Siskind, M. Jaleco, S. Shah, A. Adekile, S. Nijim, M. Laftavi

    Center for Transplantation, University Medical Center of Southern Nevada, Las Vegas, NV

    *Purpose: Donor derived malignancy is a contraindication for kidney transplantation. Published literature is devoid of instances of utilization of organs from donors with high PSA…
  • 2022 American Transplant Congress

    Cardiovascular Outcomes of Kidney Transplant Recipients Receiving Belatacept Compared to a Matched Tacrolimus

    Y. Kim1, J. Marvin1, K. Belfield1, G. Girone1, R. Formica2, E. Cohen1

    1Pharmacy, Yale New Haven Hospital, New Haven, CT, 2Section of Nephrology, Yale School of Medicine, New Haven, CT

    *Purpose: Tacrolimus (TAC), a calcineurin inhibitor (CNI), is the backbone of maintenance immunosuppression in kidney transplant recipients (KTR) but has been associated with cardiovascular (CV)…
  • 2022 American Transplant Congress

    Adding Epitope Compatibility To Deceased Donor Kidney Allocation Criteria: Recommendations From An Online Public Deliberation

    L. Edwards1, R. Sapir-Pichhadze2, P. Keown3, S. Bryan1

    1School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada, 2McGill University, Montreal, QC, Canada, 3Department of Medicine, University of British Columbia, Vancouver, BC, Canada

    *Purpose: With increasing demand for kidneys and a scarce supply, ways to reduce rejection and improve transplant outcomes are needed. One possibility is using epitope…
  • 2022 American Transplant Congress

    Early Clinical Experience With Alvr109, A Partially Hla-matched Sars-cov-2 Specific T-cell Therapy, In Immunocompromised Patients With Covid-19

    G. Haidar1, J. Jacobs2, K. Hughes2, K. McCormick2, A. Naqvi2, M. Agha2, T. Bogdanovich2, B. Johnson2, J. Kozar2, E. Lendermon2, C. Marino2, A. Raptis2, F. Silveira2, W. Marshall3, M. Miller3, E. Atillasoy3, J. Mellors2

    1University of Pittsburgh, Pittsburgh, PA, 2UPitt, Pittsburgh, PA, 3Allovir, Waltham, MA

    *Purpose: Therapies for COVID-19 in immunocompromised (IC) patients (pts), including transplant (tx) pts, are limited. We describe our experience with ALVR109, an allogeneic, partially HLA-matched…
  • « Previous Page
  • 1
  • …
  • 24
  • 25
  • 26
  • 27
  • 28
  • …
  • 190
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences